114 related articles for article (PubMed ID: 26082331)
1. Activated protein C upregulates ovarian cancer cell migration and promotes unclottability of the cancer cell microenvironment.
Althawadi H; Alfarsi H; Besbes S; Mirshahi S; Ducros E; Rafii A; Pocard M; Therwath A; Soria J; Mirshahi M
Oncol Rep; 2015 Aug; 34(2):603-9. PubMed ID: 26082331
[TBL] [Abstract][Full Text] [Related]
2. Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells.
Azzazene D; Al Thawadi H; Al Farsi H; Besbes S; Geyl C; Mirshahi S; Pardo J; Faussat AM; Jeannette S; Therwath A; Pujade-Lauraine E; Mirshahi M
Int J Oncol; 2013 Oct; 43(4):1011-8. PubMed ID: 23877403
[TBL] [Abstract][Full Text] [Related]
3. Protein C and its inhibitor in malignancy.
Suzuki K; Hayashi T
Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
[TBL] [Abstract][Full Text] [Related]
4. Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset.
Ducros E; Mirshahi S; Azzazene D; Camilleri-Broët S; Mery E; Al Farsi H; Althawadi H; Besbess S; Chidiac J; Pujade-Lauraine E; Therwath A; Soria J; Mirshahi M
Int J Oncol; 2012 Aug; 41(2):433-40. PubMed ID: 22614534
[TBL] [Abstract][Full Text] [Related]
5. Activated protein C decreases tumor necrosis factor related apoptosis-inducing ligand by an EPCR- independent mechanism involving Egr-1/Erk-1/2 activation.
O'Brien LA; Richardson MA; Mehrbod SF; Berg DT; Gerlitz B; Gupta A; Grinnell BW
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2634-41. PubMed ID: 17932312
[TBL] [Abstract][Full Text] [Related]
6. Identification of functional endothelial protein C receptor in human plasma.
Kurosawa S; Stearns-Kurosawa DJ; Hidari N; Esmon CT
J Clin Invest; 1997 Jul; 100(2):411-8. PubMed ID: 9218519
[TBL] [Abstract][Full Text] [Related]
7. Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells.
Mikuła-Pietrasik J; Uruski P; Matuszkiewicz K; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
Cell Oncol (Dordr); 2016 Oct; 39(5):473-481. PubMed ID: 27444787
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function.
Liaw PC; Neuenschwander PF; Smirnov MD; Esmon CT
J Biol Chem; 2000 Feb; 275(8):5447-52. PubMed ID: 10681521
[TBL] [Abstract][Full Text] [Related]
9. Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1.
Beaulieu LM; Church FC
Exp Cell Res; 2007 Feb; 313(4):677-87. PubMed ID: 17254565
[TBL] [Abstract][Full Text] [Related]
10. Mac-1 directly binds to the endothelial protein C-receptor: a link between the protein C anticoagulant pathway and inflammation?
Fink K; Busch HJ; Bourgeois N; Schwarz M; Wolf D; Zirlik A; Peter K; Bode C; von Zur Muhlen C
PLoS One; 2013; 8(2):e53103. PubMed ID: 23408932
[TBL] [Abstract][Full Text] [Related]
11. Endothelial protein C receptor is overexpressed in rheumatoid arthritic (RA) synovium and mediates the anti-inflammatory effects of activated protein C in RA monocytes.
Xue M; March L; Sambrook PN; Fukudome K; Jackson CJ
Ann Rheum Dis; 2007 Dec; 66(12):1574-80. PubMed ID: 17491095
[TBL] [Abstract][Full Text] [Related]
12. Haptoglobin and CCR2 receptor expression in ovarian cancer cells that were exposed to ascitic fluid: exploring a new role of haptoglobin in the tumoral microenvironment.
Garibay-Cerdenares OL; Hernández-Ramírez VI; Osorio-Trujillo JC; Gallardo-Rincón D; Talamás-Rohana P
Cell Adh Migr; 2015; 9(5):394-405. PubMed ID: 26211665
[TBL] [Abstract][Full Text] [Related]
13. Human vascular smooth muscle cells express functionally active endothelial cell protein C receptor.
Bretschneider E; Uzonyi B; Weber AA; Fischer JW; Pape R; Lötzer K; Schrör K
Circ Res; 2007 Feb; 100(2):255-62. PubMed ID: 17170365
[TBL] [Abstract][Full Text] [Related]
14. Activated protein C inhibits bisphosphonate-induced endothelial cell death via the endothelial protein C receptor and nuclear factor-κB pathways.
Seol JW; Lee YJ; Jackson CJ; Sambrook PN; Park SY
Int J Mol Med; 2011 Jun; 27(6):835-40. PubMed ID: 21424111
[TBL] [Abstract][Full Text] [Related]
15. The endothelial protein C receptor and activated protein C play a limited role in host defense during experimental tuberculosis.
Kager LM; Roelofs JJ; de Vos AF; Wieland CW; Schouten M; Meijers JC; Isermann B; Van't Veer C; Esmon CT; van der Poll T
Thromb Haemost; 2013 Apr; 109(4):726-37. PubMed ID: 23348224
[TBL] [Abstract][Full Text] [Related]
16. Thrombomodulin, a receptor for the serine protease thrombin, is decreased in primary tumors and metastases but increased in ascitic fluids of patients with advanced ovarian cancer FIGO IIIc.
Wilhelm S; Schmitt M; Parkinson J; Kuhn W; Graeff H; Wilhelm OG
Int J Oncol; 1998 Oct; 13(4):645-51. PubMed ID: 9735390
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
18. sPLA2-V inhibits EPCR anticoagulant and antiapoptotic properties by accommodating lysophosphatidylcholine or PAF in the hydrophobic groove.
López-Sagaseta J; Puy C; Tamayo I; Allende M; Cerveró J; Velasco SE; Esmon CT; Montes R; Hermida J
Blood; 2012 Mar; 119(12):2914-21. PubMed ID: 22167755
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
20. Endothelial protein C receptor and protease-activated receptor-1 mediate induction of a wound-healing phenotype in human keratinocytes by activated protein C.
Xue M; Campbell D; Sambrook PN; Fukudome K; Jackson CJ
J Invest Dermatol; 2005 Dec; 125(6):1279-85. PubMed ID: 16354200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
